Kane Biotech Inc (KNE) — Cash Flow Quality Index
Kane Biotech Inc (KNE) has a Cash Flow Quality Index of -0.24x as of June 2024. Operating cash flow of CA$-2.17 Million is below net income of CA$9.18 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of Kane Biotech Inc to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Kane Biotech Inc Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Kane Biotech Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check KNE cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Kane Biotech Inc (2024–2024)
Year-by-year earnings quality comparison for Kane Biotech Inc. For live market cap and the full company financial profile, see KNE stock market capitalisation.
| Year | Quality Index | Operating CF (CAD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.67x | CA$-4.11 Million | CA$6.10 Million | — |